-
covid 19 update
What follows is an email I received from a friend who recently retired from the CDC. Thought some of you might be interested in a pretty unbiased assessment from someone who has been working in infectious disease for 30 years as a researcher at the CDC.
As for me I have seen some Covid patients and have intubated three for the vent personally, one being a healthy 55 yo with no real medical issues. That hits close to home for this almost 62 yo. So far in Southeast TN the shelter in place seems to be keeping things under control. While the healthcare providers face the risk of infection we also are feeling the economic pain. My practice has furloughed half of our CRNAs and the physicians have take a 50% hit on pay. This is due to the cancellation of all elective procedures to conserve PPE. How I see that ending is patients scheduled for elective procedures will be tested for Covid 24-48 hours prior to surgery and will need to be negative and without a fever at the time of surgery.
i have thought about getting in the bus and running away from home many times! Here is my friends take on things:
Dear friends,
Several people have asked me for any personal insights I might have on the COVID-19 outbreak. I had some down time this afternoon as Mary and I shelter in place, so I thought it would be a good time to summarize how I see the current situation.
Flattening the curve: Here is where there is some good news. Country-wide data as well as data from New York, California, and Washington all show that the rate of new cases is slowing. A technical point on this: four different curves are sometimes shown of the daily case counts: by illness onset date, by diagnosis date, by report date, and mortality data by date of death. What you really want is by infection date, but since so many cases are asymptomatic, we won’t have good data by infection date any time soon. Data by illness onset date is the earliest indicator of flattening of the curve, and CDC has been publishing that data every day. It shows the nation’s curve began to flatten about a week ago. One thing I find interesting is that none of the big states have shown an impressive decline in the daily case counts. Italy and Spain have, but not here. South Korea, Taiwan, and Japan have experienced impressive declines in their daily case counts but have recently seen increases. There may be a limit to how much of a drop we will see. A modeling study published today concluded that the R naught in China was greater than 5 in January, meaning that on average, each infected person transmitted the infection to 5 others. China now is reporting almost no new cases except imported cases among travelers, but I don’t know how to interpret the reports by the CIA that China has not been reporting all their data.
When can we get back to normal? I have read opinion pieces by non-epidemiologists that once we get widespread antibody testing (FDA just approved an antibody test), we can get back to normal by having those with antibodies go back to work. I don’t see it. That would require a lot of otherwise normal people getting a test that is still rare. I have also read that we could let everyone under 60 go back to work, since their mortality rate is very low. I also do not see that, especially since Mary and I would be discriminated against, forced to wear a mask of shame forever. And the social distancing that is being practiced today is not because the government mandated it as much as it is because people are afraid to get infected. And, if California and Washington and New York have not seen dramatic declines in their daily case counts, I don’t see how they are going to lift restrictions until they do.
Did CDC really botch testing? Yup. I am not in the know at CDC anymore, but rumor has it that the initial CDC test had a viral RNA segment that was not a good match for all of the viruses being circulated, resulting in several false-negative results. Probably a combination of bad luck and being under pressure to move quickly. A bigger problem was that neither CDC nor FDA nor any other government agency apparently had plans for rapidly scaling testing in commercial labs. CDC normally works with state public health labs and normally does not tell commercial labs what to do.
Will the Midwest escape? There are very few cases in the Midwest, but a more important indicator than the daily case count is the rate of growth of that count. In Tennessee, cases are increasing at a doubling time of around 8 days, which is much lower than Italy or New York, but it still increasing exponentially. There does not appear to be a big difference between urban and rural Tennessee. It might be that the Midwest does not see the explosive growth that the coastal big cities did, but maybe we will all end up in the same place with a sustained number of new cases for a long time.
Treatment and vaccinations and immunity: I have been involved in a lot of clinical trials where promising initial results were shown to be false when properly designed studies were done. I would guess that the same thing will be the case with hydroxychloroquine. Recent anecdotal reports in this country have shown unimpressive results, but these reports have focused on the most ill patients. A drug might show substantial benefit at the early stages of an infection but much less later on. Since most patients improve without treatment, it will take a very large clinical trial before you can be certain a drug does or does not work. Tony Fauci has reported promising results from at least one vaccine in lab animals. I was also impressed to hear Bill Gates say that his foundation was testing 7 vaccines and already ramping up production for each one so that when the best vaccine was identified, they could scale production quickly. Not so good news was reported today that many Chinese who had recovered from covid-19 did not have neutralizing antibodies. This means that there is no guaranteed that infection confers protective immunity in all or that a vaccine will be highly effective. Yikes.
Log in to reply.